| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/05/2011 | US20110104066 Prophylactic/therapeutic agents for lifestyle-related diseases |
| 05/05/2011 | CA2779398A1 Novel 3-hydroxy-5-arylisoxazole derivative |
| 05/05/2011 | CA2779162A1 Concentrated therapeutic phospholipid compositions |
| 05/05/2011 | CA2779073A1 Novel oxime derivatives and their use as allosteric modulators of metabotropic glutamate receptors |
| 05/05/2011 | CA2778990A1 Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same |
| 05/05/2011 | CA2778949A1 Imidazo[1,2-b]pyridazine derivatives and their use as pde10 inhibitors |
| 05/05/2011 | CA2778890A1 Glycosylated form of antigenic glp-1 analogue |
| 05/05/2011 | CA2778684A1 Bridged bicyclic piperidine derivatives and methods of use thereof |
| 05/05/2011 | CA2778669A1 Composition to induce specific immune tolerance |
| 05/05/2011 | CA2777857A1 Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives |
| 05/05/2011 | CA2775413A1 Compounds for the treatment of dyslipidemia and related diseases |
| 05/05/2011 | CA2775249A1 Therapeutic gas for the treatment of mitochondrial disorders |
| 05/04/2011 | EP2316968A1 Antisense modulation of apolipoprotein (A) expression |
| 05/04/2011 | EP2316951A1 Binding domain-immunoglobulin fusion proteins |
| 05/04/2011 | EP2316944A2 Binding agents: chimeric ligand/receptor proteins |
| 05/04/2011 | EP2316939A2 Novel peptide |
| 05/04/2011 | EP2316919A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 05/04/2011 | EP2316918A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 05/04/2011 | EP2316851A1 Antibody inhibitors of GDF-8 and uses thereof |
| 05/04/2011 | EP2316845A1 Specific binding agents of human angiopoietin-2 |
| 05/04/2011 | EP2316828A1 Piperazine derivatives and their use as therapeutic agents |
| 05/04/2011 | EP2316827A1 Piperazine derivatives and their use as therapeutic agents |
| 05/04/2011 | EP2316826A1 Pyridazine derivatives and their use as therapeutics agents |
| 05/04/2011 | EP2316825A1 Pyridyl derivatives and their use as therapeutic agents |
| 05/04/2011 | EP2316529A1 Compositions and methods for treatment of body weight conditions with enzyme inhibiting peptides |
| 05/04/2011 | EP2316488A1 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
| 05/04/2011 | EP2316470A2 Peptidomimetic inhibitors of post-proline cleaving enzymes |
| 05/04/2011 | EP2316466A2 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation |
| 05/04/2011 | EP2316458A1 Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase |
| 05/04/2011 | EP2316457A1 Pyridine derivatives for inhibiting human stearoyl-coa-desaturase |
| 05/04/2011 | EP2316456A1 Compositions for affecting weight loss comprising naltrexone and bupropion |
| 05/04/2011 | EP2316455A1 Pharmaceutical compositions for treating cancer |
| 05/04/2011 | EP2316450A1 Amino-methyl substituted tetracycline compounds |
| 05/04/2011 | EP2316447A1 Method of inhibiting remnant lipoprotein production |
| 05/04/2011 | EP2316446A1 Counteracting drug-induced obesity using GLP-1 agonists |
| 05/04/2011 | EP2316445A1 HUMAN beta3 ADRENERGIC RECEPTOR LIGAND, AND FOOD OR PHARMACEUTICAL PRODUCT CONTAINING THE SAME |
| 05/04/2011 | EP2315766A1 Octahydroquinolizines for antidiabetic treatment |
| 05/04/2011 | EP2315745A2 2-methylene-19, 26-dinor-(20s, 22e, 25r)-vitamin d analogs |
| 05/04/2011 | EP2315744A2 2-methylene-20(21)-dehydro-19-nor-vitamin d analogs |
| 05/04/2011 | EP2315600A2 Compositions and methods related to sirt1 function |
| 05/04/2011 | EP2048145B9 Protein kinase c activity enhancer containing alkyl ether derivative or salt thereof |
| 05/04/2011 | EP1515615B1 Nutritional composition for detoxification and cancer prevention |
| 05/04/2011 | EP1446100B1 Injectable depot compositions and uses thereof |
| 05/04/2011 | EP1414439B1 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 05/04/2011 | EP1317448B2 Pyrazole compounds useful as protein kinase inhibitors |
| 05/04/2011 | EP1294746B1 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
| 05/04/2011 | CN201814844U Fumigating belt for a plurality of pulse |
| 05/04/2011 | CN1968949B Proline derivatives and their use as dipeptidyl peptidase IV inhibitors |
| 05/04/2011 | CN1847229B 2,4,8- trisubstituted-8H- pyridine[2,3-d] pyridine -7-one compound |
| 05/04/2011 | CN1634885B Novel mitiglinide crystalline form and its preparing process |
| 05/04/2011 | CN102046645A Crystal of spiroketal derivative, and process for production thereof |
| 05/04/2011 | CN102046600A New crystalline pyrithione/zinc oxide complex and physiologic/antibiotic active composite containing the same |
| 05/04/2011 | CN102046185A Composition comprising 1, 3 /1, 6 beta glucan for reducing weight |
| 05/04/2011 | CN102043030A Method for measuring materials associated with niacin simvastatin sustained-release tablets by high performance liquid chromatography |
| 05/04/2011 | CN102040667A Method for biologically removing protein from sea cucumber polysaccharide |
| 05/04/2011 | CN102040644A Tanshinone derivative as well as preparation and application thereof |
| 05/04/2011 | CN102040627A Phosphorus-containing compound and its medicament application for treatment of bone metabolism abnormity |
| 05/04/2011 | CN102040621A Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders |
| 05/04/2011 | CN102040603A Brominated N-o-methoxycarbonylbenzyl tetrahydroberberine and application thereof in treatment of hyperlipidemia |
| 05/04/2011 | CN102040601A 1-N-(1-azabicyalo(2,2,2) octane ether compound and application thereof |
| 05/04/2011 | CN102040569A Carotinoid derivatives and preparation method and application thereof |
| 05/04/2011 | CN102040549A Statin compound, preparation method and medicament application thereof in blood fat regulation |
| 05/04/2011 | CN102040517A Resveratrol derivative and application thereof to medicament |
| 05/04/2011 | CN102040516A Resveratrol derivative and medical application thereof |
| 05/04/2011 | CN102038900A Traditional Chinese medicine prescription for treating obesity |
| 05/04/2011 | CN102038887A Formula of functional proteome for quickly supplementing human albumin and preparation method thereof |
| 05/04/2011 | CN102038876A Efficient diet pills |
| 05/04/2011 | CN102038864A Application of Chinese medicinal composition in preparation of medicament for treating diabetic cardiomyopathy |
| 05/04/2011 | CN102038859A Traditional Chinese medicine preparation for treating diabetes |
| 05/04/2011 | CN102038855A Medicament for treating diabetes |
| 05/04/2011 | CN102038846A Chinese medicinal preparation for treating blood-deficiency diabetes mellitus |
| 05/04/2011 | CN102038827A Chinese medicinal preparation for treating diabetes with hypertension |
| 05/04/2011 | CN102038813A Coconut palm leaf extract and preparation method and use thereof |
| 05/04/2011 | CN102038805A Formula of traditional Chinese medicinal diet tea |
| 05/04/2011 | CN102038800A Retained fluid prescription for treating hypertension and preparation method thereof |
| 05/04/2011 | CN102038774A Drug or health-care food with lipid-lowering and liver-protecting effects |
| 05/04/2011 | CN102038767A Application of effective part of Chinese dates and rutin in preparation of antilipemic drug and antilipemic drug |
| 05/04/2011 | CN102038745A Hypolipidemic traditional Chinese medicine |
| 05/04/2011 | CN102038737A Method for extracting persimmon leaf essence |
| 05/04/2011 | CN102038731A Original herb of common sowthistle hard capsules |
| 05/04/2011 | CN102038730A Patrinia scabiosaefolia primitive hard capsules |
| 05/04/2011 | CN102038727A Method for preparing purified alkaloid part in Chinese angelica-szechuan lovage rhizome supercritical CO2 extract |
| 05/04/2011 | CN102038726A Method for preparing organic acid part purified from angelica sinensis-ligusticum wallichii supercritical CO2 extractive |
| 05/04/2011 | CN102038720A Fuscoporia obliqua active ingredients capable of lowering blood sugar and preparation method and application of fuscoporia obliqua active ingredients |
| 05/04/2011 | CN102038713A Method of producing a dry earthworm powder |
| 05/04/2011 | CN102038691A Composite preparation of vitamins and amino acids and preparation method thereof |
| 05/04/2011 | CN102038682A Pharmaceutical composition containing amlodipine and atorvastatin calcium solvate |
| 05/04/2011 | CN102038671A Medicinal composition containing levocarnitine and hydroxybenzene sulfonate |
| 05/04/2011 | CN102038670A Calcium and zinc gluconate oral solution and preparation method thereof |
| 05/04/2011 | CN102038666A Medicament for treating or preventing metabolic diseases and application thereof |
| 05/04/2011 | CN102038619A Bathing particles and preparation method thereof |
| 05/04/2011 | CN102038179A Prescription of beverage for treating diabetes and preparation method thereof |
| 05/04/2011 | CN101700354B Traditional Chinese medicine for treating diabetes |
| 05/04/2011 | CN101693041B Transdermal zinc supplement |
| 05/04/2011 | CN101596169B Chitosan nanoparticle for encapsulating adenosine triphosphate and preparation method thereof |
| 05/04/2011 | CN101575326B Method for extracting tea polyphenol from glede tea |
| 05/04/2011 | CN101548961B Novel oral capsule preparation for curing diabetes mellitus and obesity |
| 05/04/2011 | CN101491608B Medicine of effective fractions of compounded prescription of Huomai Tiaozhi capsule and preparation technology thereof |
| 05/04/2011 | CN101461845B Rumex nepalensis Spreng. extract as well as preparation method and use thereof |
| 05/04/2011 | CN101445566B Arginine amino polysaccharide containing NO increasing and releasing agent and production method thereof |